Effects of raloxifene on adipocytokines in Japanese osteoporotic postmenopausal women with and without type 2 diabetes.
Murase
Y
Y
Department of Molecular Genetics of Cardiovascular Disorders, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan. in1254@poh.osaka-med.ac.jp
Kobayashi
J
J
Asano
A
A
Yamaaki
N
N
Yonezawa
K
K
Muramoto
H
H
Mabuchi
H
H
D000273:Adipose Tissue / Q000378:metabolism*; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D050218:Body Fat Distribution / Q000379:methods; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D016207:Cytokines / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000150:complications / Q000188:drug therapy; D007564:Japan; D015663:Osteoporosis, Postmenopausal / Q000097:blood* / Q000150:complications / Q000517:prevention & control; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage*
D015415:Biomarkers; D050071:Bone Density Conservation Agents; D016207:Cytokines; D020849:Raloxifene Hydrochloride